Amfil Technologies Inc (FUNN)

[slambino]

Proven Technology, First-Mover Advantage (full article http://www.cannabisfn.com/booming-cannabis-industrys-need-for-quality-control-can-be-solved/)

Enter Amfil Technologies, Inc. (OTC: AMFE), which teamed up with Antibacterial Cleaning Treatment Services, Inc. (ACTS) a few months ago via a definitive JVA to adapt ACTS’s proven mPact™ Cleaning Antimicrobial System’s core ozone technology for the marijuana industry. Originally designed for multi-surface (from walls and floors to vats and prep surfaces) cleaning and antimicrobial treatment, mPact is an established technology in the food and beverage, as well as fresh produce industries. With a solid track-record of installed hardware helping to secure food safety compliance at critical production infrastructure for major players like SYSCO Corp. (NYSE: SYY) and Nestle (OTC: NSRGY), mPact carries quite a pedigree with it into the marijuana business.

The first unit in the company’s mPact -GROzone Antimicrobial System product line, the mPact -GROzone 60™, has already seen successful installation at one of the state-of-the-art cultivation facilities belonging to commercially licensed Today’s Health Care (THC), Colorado’s premier medical marijuana organization. Engaged in both production and retail, THC has four modern retail locations, 18k square feet of indoor hydroponics, and 26k square feet of greenhouses (being expanded to 56k). THC plans to build one of the biggest indoor hydroponic cultivation facilities in the state as well (some 200k sq. ft.), making this relationship a potentially very bright one indeed for Amfil Technologies. Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical products and services company establishing itself in the sector, which has paid and acquired an initial ownership interest in Amfil Technologies (with an option to purchase 32.5% or more), is setting up the field for themselves with an exclusive option to purchase up to 50% ownership interest in a private medical marijuana grower which already has received a letter to build from Health Canada, prior to getting its license under MMPR (one of only 43 growers at this phase). This could set Easton Pharma up for a play similar to the one executed so expertly by GW Pharmaceuticals (NASDAQ: GWPH), which is at the cutting edge of full-spectrum cannabinoid research, with control over their entire production pipeline and a plant-based prescription pharmaceutical portfolio that includes the multiple sclerosis indication, Sativex®.

The mPact -GROzone 60 is a triple-function sanitization unit capable of naturally eliminating 99.9% of airborne pathogens and the typically problematic pests that wreak havoc for cultivators (like aphids, whiteflies and spider mites), as well as bacteria, fungus, microbes and mold on surfaces, all without chemicals. The unit can also constantly regulate a given facility’s water supply, oxygenating the water and maintaining a consistent PPM infusion of ozone that prevents the formation of algae, bacteria or mold (allowing for comprehensive water recycling), simultaneously removing the need to use dangerous, often carcinogenic products to treat the water, as is common throughout the industry today. This environmentally-friendly solution also eliminates odors, while slightly reducing the air temperature, lowering energy consumption by the HEPA filtration and HVAC systems. There is even compelling research indicating that elevated levels of ozone and CO2 can produce yields having as much as 53% more total biomass in certain plant types, with similar results for seed production.